Read this article now - Try Goliath Business News - FREE!   
You can view this article PLUS...

• Over 5 million business articles
• Hundreds of the most trusted magazines, newswires, and journals (see list)
• Premium business information that is timely and relevant
• Unlimited Access

Tell Me More   Terms and Conditions

Purchase this article for $4.95

...is www.aids2002.com. Below are some research and treatment highlights from this year's 14th International AIDS Conference.

DOES GENDER PREDICT T CELL RESPONSE TO HAART?

Studies have shown that Blacks and Hispanics with AIDS have a greater likelihood of dying than Whites with AIDS and that women with AIDS have a 20% greater likelihood of dying than men with AIDS. A study conducted at Houston's Thomas Street Clinic by Baylor of College of Medicine researchers looked at whether the T cell response of persons who had "sustained viral suppression" differed by ethnicity or gender, and whether this difference in T cell response might account for the difference in survival. "Sustained viral suppression" was defined as 2 consecutive viral load counts less than 400, the last of which was at least 120 to 240 days from the beginning of highly active antiretroviral therapy (HAART). A total of 79 men and 24 women were included in this analysis. Even after adjusting for variables like AIDS, baseline viral load and T cell count, and use of a protease inhibitor, women were found to have a better T cell response (+66 cells) to sustained viral suppression than men. No difference was found by ethnicity. The researchers conclude that "gender-specific optimal therapy needs to be defined."

GETTING HIV TWICE

Doctors and physicians have debated the question of whether a person can be infected with HIV and then re-infected with another strain. In other words, once you have an established infection with one strain of the virus, can you get another...

NOTE: All illustrations and photos have been removed from this article.



More articles from HIV Treatment: ALERTS!
Keeping it real: nothing lasts forever.(HIV drug supply and demand), September 01, 2002
Patient/Doctor: Q&A., September 01, 2002
Calendar.(Calendar), September 01, 2002
Clinical trial information.(various reports on AIDS treatment research..., September 01, 2002
Mental health issues: with HIV/AIDS., September 01, 2002

Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.